Page 1,709«..1020..1,7081,7091,7101,711..1,7201,730..»

Euro Biotechnology Congress

Posted: September 18, 2016 at 12:44 am

Track 1:Pharmaceutical Biotechnology

Pharmaceutical Biotechnology is the science that covers all technologies required for producing, manufacturing and registration of biological drugs.Pharmaceutical Biotechnologyis an increasingly important area of science and technology. It contributes in design and delivery of new therapeutic drugs,diagnosticagents for medical tests, and in gene therapy for correcting the medical symptoms of hereditary diseases. The Pharmaceutical Biotechnology is widely spread, ranging from many ethical issues to changes inhealthcarepractices and a significant contribution to the development of national economy.Biopharmaceuticalsconsists of large biological molecules which areproteins. They target the underlying mechanisms and pathways of a disease or ailment; it is a relatively young industry. They can deal with targets in humans that are not accessible with traditional medicines.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrialBiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA; Global Biotechnology Congress 2016, May 11th - 14th 2016, Boston, MA, USA;BiomarkerSummit 2016, March 21-23, 2016 San Diego, CA, USA; 14th Vaccines Research & Development, July 7-8, 2016 Boston, USA; Pharmaceutical &Biotech Patent LitigationForum, Mar 14 - 15, 2016, Amsterdam, Netherlands;

Track 2:Biotechnology in Health Care

Biotechnology in health care represents the complex of modern biological approaches in the field of healthcare research and industry. Healthcare Biotechnology methods are used primarily in pharmaceutical industry and modern clinical diagnostics. The research training in this domain is programmed for the candidates intending to develop their careers in scientific-research institutions, clinical anddiagnostic laboratories, analytical services,pharmacologicalandpharmaceutical companies, etc. For the first time in the history of human healthcare, biotechnology is enabling the development and manufacturing of therapies for a number of rare diseases with a genetic origin. Although individually rare, collectively thesediseasesaffect some 20-30 million individuals and their families with 70-80% having a genetic component requiring biotechnology as part of the solution.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrialBiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA; 3rd CaribbeanBiomedicalResearch Days, January 16-18, 2016, Rodney Bay, Saint Lucia; GlobalBiotechnologyCongress 2016, May 11th-14th 2016, Boston, MA, USA;BiomarkerSummit 2016, March 21-23, 2016 San Diego, CA, USA; 14thVaccinesResearch & Development, July 7-8, Boston, USA;Pharmaceutical&BiotechPatentLitigation Forum, Mar 14 - 15, 2016, Amsterdam, Netherlands; 4thBiomarkersinDiagnostics, Oct 07-08, 2015 Berlin, Germany, DEU.

Track 3:Food Biotechnology

Food biotechnology is a process scientists use to enhance the production,nutritional value, safety, and taste of foods. It can also benefit the environment by improving crops so that they need fewerpesticides. The concept is not new: For centuries farmers have selectively bred plants to pass on desirable qualities. For example, our ancestors began by replanting only corn seeds from the highest yielding and best tasting corn they grew each year. This process selected desirable genes and fixed them by growing the seeds of the selected crop year after year. The result: the golden, deliciously sweet product we now enjoy. Modernfood biotechnologyis a refined version of this same process. Today, scientists obtain desired traits by adding or removing plant genes. This process is called genetic engineering or recombinant DNA technology. It yields foods that are flavorful, contain more vitamins and minerals, and absorb less fat when cooked, and gives us crops that are more resistant to pests and insects. Food biotechnology holds great promise for the future. Soon, fruits and vegetables may be made to resist drought. We may remove allergens from foods such as nuts. Scientists may develop plants that absorb nitrogen more efficiently and need lessfertilizer. The benefits are nearly limitless!

RelatedBiotechnology Conferences

3rdGlobal Food Safety Conference, September 01-03, 2016, Atlanta USA; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrialBiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;BiologicallyActive Compounds inFood, October 15-16 2015 Lodz, Poland; World Conference on InnovativeAnimal NutritionandFeeding, October 15-17, 2015 Budapest, Hungary; 18th International Conference onFood ScienceandBiotechnology, November 28 - 29, 2016, Istanbul, Turkey; 18th International Conference onAgricultural Science,Biotechnology,FoodandAnimal Science, January 7 - 8, 2016, Singapore; International IndonesiaSeafood and Meat, 1517 October 2016, Jakarta, Indonesia; International Conference of Eco-friendlyApplied BiologicalControl ofAgricultural PestsandPhytopathogens, 19 -22 October 2015, Cairo, Egypt;Food Structures,DigestionandHealth3rd International Conference, 28-30 October, Wellington, New Zealand; Conference ofCereal BiotechnologyandBreeding, November 2-4, 2015, Berlin, Germany; AdvancedWater TreatmentforFood & Beverage, November 3-4, 2015 Amsterdam, Netherlands.

Track 4:Industrial and Microbial Biotechnology

Industrial or white biotechnology uses enzymes and micro-organisms to make biobased products in sectors such as chemicals,food and feed, detergents, paper and pulp, textiles andbioenergy. The application of industrial biotechnology has been proven to make significant contributions towards mitigating the impacts of climate change in these and other sectors. In addition to environmental benefits, biotechnology can improve industrys performance and product value and, as the technology develops and matures,white biotechnologywill yield more and more viable solutions for our environment. These innovative solutions bring added benefits for both our climate and our economy.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrialBiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA; BIO IPCC Conference, Cary, North Carolina, USA; World Congress onIndustrial Biotechnology, April 17-20, 2016, San Diego, CA; The European Forum forIndustrial Biotechnologyand theBioeconomy, 27-29 October 2015, Brussels, Belgium; 4thBiotechnologyWorld Congress, February 15th-18th, 2016, Dubai, United Arab Emirates; International Conference on Advances inBioprocess EngineeringandTechnology, 20th to 22nd January 2016,Kolkata, India; GlobalBiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA

Track 5:Nanobiotechnology

Nanobiotechnologyis beginning to allow scientists, engineers, and physicians to work at the cellular and molecular levels to produce major benefits to life sciences and healthcare. In the next century, the emerging field of nanotechnology will lead to new biotechnology based industries and novel approaches in medicine. Nanobiotechnology is that branch of nanotechnology that deals with biological and biochemical applications or uses. Nanobiotechnology often studies existing elements of living organisms and nature to fabricate newnano-devices. Generally, nanobiotechnology refers to the use of nanotechnology to further the goals of biotechnology. Some of the innovative challenges in the field of biology are: New molecular imaging techniques, Quantitative analytical tools, Physical model of the cell as a machine, Better ex-vivo tests and improvement in current laboratory techniques and Better drug delivery systems.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;NanoBioTech-Montreux, November 16-18, 2015, Switzerland; International Conference onNanobiotechnology(ICNB'16), April 1-2, 2016, Prague, Czech Republic; InternationalNanotechnologyConference & Expo, April 4-6, 2016 Baltimore, USA;

Track 6:Plant Biotechnology

Plant biotechnology is the technique used to manipulate the plants for specific needs or requirement. In traditional process seed is the major source for germinating a new plant but the advance method is independent that combines multiple needs to get the required traits.Plant biotechnologymeets the challenge that includesgenomics,genetic engineering,tissue culture, andtransgenic cropsetc. These biotechnological applications allow researchers to detect and map genes and discover their functions, selection of specific genes in genetic resources and its breeding and to customize the plant according to the requirement by transferring the genes of specific traits to combine with others to create a new species. The recent advances in plant biotechnology provide potential way to make improvements much more quickly than conventionalplant breedingtechniques. Plant tissue culture is a part of plant biotechnology which is the collection of many techniques that is used to maintain and grow plant, plant cells, plant tissues under controlled sterile conditions over the nutrient medium. Plant tissue culture is the convenient method produce clones of a plant through the process calledmicropropagation. The main advantage of this method is to produce exact and multiple copies of plants with good desired properties like good flowers, fruits and other characters within small span of time. Production of multiple plants without seed, production of genetically modified plants, the tissue culture plants are resistant to the diseases,pathogensand pests, also it is the best method to store the gene pools and many more

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrialBiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA; 3rd CaribbeanBiomedicalResearch Days, January 16-18, 2016, Rodney Bay, Saint Lucia;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA; 18th International Conference onAgricultural Biotechnology, Biological and Biosystems Engineering, January 18-19, 2016, London, United Kingdom; 2nd International Conference on Biotechnology andAgriculture EngineeringApril 08-09 2016 in Tokyo, Japan; Food Structures, Digestion andHealth3rd International Conference, 28-30 October 2015, Wellington, New Zealand; 3rd Conference ofCereal Biotechnologyand Breeding, November 2-4, 2015, Berlin, Germany;

Track 7:Agricultural Biotechnology

Agricultural biotechnologyis the area of biotechnology involving applications to agriculture. Agricultural biotechnology has been practiced for a long time, as people have sought to improve agriculturally important organisms by selection and breeding. An example of traditional agricultural biotechnology is the development of disease-resistant wheat varieties by cross-breeding different wheat types until the desired disease resistance was present in a resulting new variety. Modern agricultural biotechnology improves crops in more targeted ways. The best known technique is genetic modification, but the term agricultural biotechnology (or green biotechnology) also covers such techniques as Marker Assisted Breeding, which increases the effectiveness of conventional breeding. Whatever the particular technology used, the crops may be destined for use for food,biomaterialsor energy production.Genetic modificationmeans that existing genes are modified or new genes included to give plant varieties desirable characteristics, such as resistance to certain pests or herbicides, or forvitaminfortification. Because only a few genes with known traits are transferred, GM methods are more targeted and faster thantraditional breeding. Biotechnology has helped to increase crop productivity by introducing such qualities as disease resistance and increased drought tolerance to the crops.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrialBiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA; Conference onAgricultural Statistics2015, Sarawak, Malaysia; 2nd International Conference onGlobal Food Security, 11-14 October 2015, Ithaca, United States; 5th International Conference onOrganic AgricultureSciences, 14th-17th October 2015, Bratislava, Slovakia; 18thInternational Conference onAgricultural, Biotechnology, Biological and Biosystems Engineering, January 18-19, 2016, London, United Kingdom; 2nd International Conference on Biotechnology andAgriculture EngineeringApril 08-09 2016 in Tokyo, Japan;Food Structures, Digestion andHealth3rd International Conference, 28-30 October 2015, Wellington, New Zealand; 3rd Conference of Cereal Biotechnology andBreeding, November 2-4, 2015, Berlin, Germany; AdvancedWater TreatmentforFood & Beverage, 3-4 Nov 2015, Amsterdam, Netherlands

Track 8:Environmental Biotechnology

Environmental biotechnology is biotechnology that is applied to and used to study the natural environment. Environmental biotechnology could also imply that one try to harness biological process for commercial uses and exploitation. The International Society for Environmental Biotechnology defines environmental biotechnology as "the development, use and regulation of biological systems for remediation of contaminated environments (land, air, water), and for environment-friendly processes (green manufacturing technologies and sustainable development)

RelatedBiotechnology Conferences

5th International Conference onBiodiversity, March 10-12, 2016 at Madrid, Spain; International Conference on Biotechnology andEnvironmental ManagementSeptember 14-15 Milan, Italy; 6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA; International Conference onGreen Energy& Expo September 21-23, 2015 Orlando, FL, USA; International Conference on Environment,Energy and Biotechnology, May 25, 2016 Jeju Island, Republic of Korea; International Conference on Energy andEnvironmental Biotechnology, November 24 - 25, 2015 Dubai, UAE; Science for theEnvironmentConference 2015, October 1-2 2016 Aarhus, Denmark; International Conference onEnvironmental Scienceand Technology 14th to 17th May 2016, Antalya, Turkey

Track 9:Marine Biotechnology

Marine Biotechnology is a relatively new field of study, having emerged in the past few years. The Marine Biotechnology is intended to host scientific contributions inmarine sciencethat are based on the enormousbiodiversityof marine ecosystems and the genetic uniqueness of marine organisms to develop useful products and applications.Aquaculture& Marine Biotechnology have been the subject of great importance not only because of the sustainable utilization of their resources to feed the billion people of the world but also for the future challenges for discovery of new products and process development of economic importance through its treasure recognition and diversification. Apart from contributing to high quality and healthy food (aquaculture),nutraceuticalsand medicinal products (anti-cancer andantimicrobials), this sector is expected to contribute to sustainable alternative source of energy (biofuelfrom microalgae) and environmental health. Marine Biotechnology is capable of making an important contribution towards meeting impending challenges like a sustainable supply of food and energy and human health.

RelatedBiotechnology Conferences

5th International Conference on Biodiversity, March 10-12, 2016 at Madrid, Spain; International Conference on Biotechnology and Environmental Management September 14-15, Milan, Italy; 6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;BioMarine2015, 12-14 Oct 2016, Wilmington, NC, United States; International Conference onMarine BiotechnologyandBioprocessing, December 10 - 11, 2015, Sydney, Australia; Annual world congress ofMarine Biotechnology-2015, November 6-8 2015, Qingdao, China;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA; Annual InternationalMarine BiotechnologyConference, Nov 20, 2013, Brisbane, Australia

Track 10:Current Scenario of Biotechnology

Due to multidisciplinary nature of the field of biotechnology, a wide range of different branches of science have made significant contributions to the fast development of this field. Some of these disciplines are-biochemical engineering,physiology,biochemistry,food science,material science,bioinformatics,immunology,molecular biology,chemical engineeringetc. Biotechnology is also improving the lives of people around the world. Biotechnology also has affected economy in a positive way due to the creation and growth of small business, generation of new jobs. Agricultural biotechnology has reduced our dependency on pesticides.Bioremediation technologiesare being used to clean our environment by removing toxic substances from contaminated ground water and soils. about 60% of the biotechnology products in the market are healthcare products and 21% are products used in agriculture andanimal husbandry. A considerable amount of efforts in research are on, to use and extract benefit from this interesting and upcoming field for the betterment of human life and the environment. Many biochemical companies are involved in the production of biotechnological products usinggenetic engineeringtechniques.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA;

Track 11:Animal Biotechnology

Biotechnology provides new tools for improvinghuman healthand animal health and welfare and increasinglivestock productivity. Biotechnology improves the food we eat-meat, milk and eggs. Biotechnology can improve an animals impact on the environment. And biotechnology enhances ability to detect, treat and prevent diseases. Just like other assistedreproduction techniquessuch asartificial insemination,embryo transferandin vitro fertilization, livestockcloningimproves animal breeding programs allowing farmers and ranchers to produce healthier offspring, and therefore producer healthier, safer and higher quality foods more consistently.

RelatedBiotechnology Conferences|Biotechnology Events|Biochemistry Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA;BiomarkerSummit 2016, March 21-23, 2016 San Diego, CA, USA; 14thVaccinesResearch & Development, July 7-8, Boston, USA;

Track 12:Biomass and Bioenergy

Bioenergyis the chemical energy contained in organic matter (biomass) which can be converted into energy forms that we can use directly, such as electricity, heat and liquid fuel. Biomass is any organic matter of recently living plant or animal origin. Unlike coal, the organic matter is notfossilised.Bioenergy plantscan range from small domestic heating systems to multi-megawatt industrial plants requiring hundreds of thousands of tonnes ofbiomassfuel each year. A variety of technologies exists to release and use the energy contained in biomass. They range from combustion technologies that are well proven and widely used around the world for generating electricity generation, to emerging technologies that convert biomass intoliquid fuelsfor road, sea and air transport.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA; IEABioenergyConference 2016, October 26th-29th2016, Berlin, Germany; Summit onIndustrial biotechnologyandBioenergy, December 7 -9, 2016 San Diego, California; Energy Conference, Des Moines, Oct 13-15 Iowa, USA; EuropeanBiomassConference and Exhibition Amsterdam, 6-9, June, Germany Netherlands; EcoSummit 2016, August 29 - September 01 2016, Montpellier, France; InternationalBioenergyand Bioproducts Conference, October 28-30, 2016 Atlanta, Georgia; 2016 InternationalBiomassConference & Expo, Charlotte, North Carolina;World Bioenergy2016, May 24-26 2016, Stockholm, Sweden; 2016 InternationalFuel EthanolWorkshop & Expo, June 20-23, 2016 Milwaukee, Wisconsin.

Track 13:Biotechnology and its Applications

The applications of biotechnology are so broad, and the advantages so compelling, that virtually every industry is using this technology. Developments are underway in areas as diverse aspharmaceuticals, diagnostics,textiles,aquaculture,forestry, chemicals, household products,environmental cleanup,food processingand forensics to name a few. Biotechnology is enabling these industries to make new or better products, often with greater speed, efficiency and flexibility. Biotechnology holds significant promise to the future but certain amount of risk is associated with any area.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA; IEABioenergyConference 2016, October 26th-29th2016, Berlin, Germany; Summit onIndustrial biotechnologyandBioenergy, December 7 -9, 2016 San Diego, California;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA;

Track 14:Biotechnology Market

The growth of Biotechnology industry as per Transparency Market Research is estimated to observe substantial growth during 2010 and 2017 as investments from around the world are anticipated to rise, especially from emerging economical regions of the world. The report states that the global market for biotechnology, studied according to its application areas, shall grow at an average annual growth rate of CAGR 11.6% from 2012 to 2017 and reach a value worth USD 414.5 billion by the end of 2017. This market was valued approximately USD 216.5 billion in 2011. The market of bioagriculture, combined with that of bioseeds, is projected to reach a value worthUSD 27.46 billionby 2018. The field of biopharmaceuticals dominated the global biotechnology market and accounted for 60% shares of it in the year 2011. Many biotechnological industries flourished by the technological advancements leading to new discoveries and rising demands from the pharmaceutical and agricultural sectors.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA;BIO Investor Forum, October 20-21, 2015, San Francisco, USA; BIO Latin America Conference, October 14-16, 2015, Rio de Janeiro, Brazil; BioPharm Americ 2015-8thAnnual International Partnering Conference, September 15-17, 2015, Boston, MA, USA;

Track 15: Biotech Companies and Market Analysis

The biotechnology community in Europe has seen significant growth in recent years. By establishing itself in several key niche markets, the European biotech and pharma industries have thrived in the global biopharmaceutical market. Europe high standards for their life science educational systems have increased the level of growth and the quality of Europes workforce and broadened Europes reach within the world. With a dedication to innovation and research, Europe has established itself as a leader in biotechnology.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA;BIO Investor Forum, October 20-21, 2015, San Francisco, USA; BIO Latin America Conference, October 14-16, 2015, Rio de Janeiro, Brazil; BioPharm Americ 2015-8thAnnual International Partnering Conference, September 15-17, 2015, Boston, MA, USA;

Track 16: Biotech Startups and Funding:

Biotechnology being an emerging industry, game-changing strategies and relevant application of the knowledge-intelligence resource pool, drive the process of growth. Europe Biotechnology seeks to enhance, enrich and encourage newer innovations, path-breaking discoveries and effective solutions in the industry by offering a vibrant global platform for convergence of the key stakeholders - Biotech & Biopharma Companies, research institutions, investors, service providers, policy makers, regulators and analysts.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA;BIO Investor Forum, October 20-21, 2015, San Francisco, USA; BIO Latin America Conference, October 14-16, 2015, Rio de Janeiro, Brazil; BioPharm Americ 2015-8thAnnual International Partnering Conference, September 15-17, 2015, Boston, MA, USA;

Track 17: Advances in Biotech Manufacturing

The biotechnology community in Asia has seen significant growth in recent years. By establishing itself in several key niche markets, the European biotech and pharma industries have thrived in the global biopharmaceutical market. Asias high standards for their life science educational systems have increased the level of growth and the quality of Asias workforce and broadened Asias reach within the world. With a dedication to innovation and research, Asia has established itself as a leader in biotechnology.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA;BIO Investor Forum, October 20-21, 2015, San Francisco, USA; BIO Latin America Conference, October 14-16, 2015, Rio de Janeiro, Brazil; BioPharm Americ 2015-8thAnnual International Partnering Conference, September 15-17, 2015, Boston, MA, USA;

Track 18: Biotech Investors and Grants

The biotechnology industry hauled in $2.3 billion worth of venture capital investments during the second quarter of this yeara 32% increase over the prior quarter, according to the newest MoneyTree Report from PricewaterhouseCoopers (PwC) and the National Venture Capital Association (NVCA), with data from Thomson Reuters. The 126 deals struck during the period marked the biggest quarterly investment in biotech since the MoneyTree report first came out in 1995, and it brought the total for the first half to $3.8 billion.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA;BIO Investor Forum, October 20-21, 2015, San Francisco, USA; BIO Latin America Conference, October 14-16, 2015, Rio de Janeiro, Brazil; BioPharm Americ 2015-8thAnnual International Partnering Conference, September 15-17, 2015, Boston, MA, USA;

8th Euro Biotechnology Congress (Euro Biotechnology-2015) was held during August 18-20, 2015 at Flemings Conference Hotel, Frankfurt, Germany. The conference was marked with the attendance of Editorial Board Members of supported OMICS Group Journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 30 countries, who made this conference fruitful and productive.

This conference was based on the theme Biotechnology for a Better Tomorrow which included the following scientific tracks:

Biotechnology in Health Care Environmental Biotechnology Industrial Aspects of Biotechnology Stem Cells and Regenerative Medicine Marine Biotechnology and Aquaculture Agriculture Biotechnology Animal Biotechnology Food and Bio Process Biotechnology Cell and Molecular Biology Nanobiotechnology Genetic Engineering and rDNA Technology Current Scenarios and other allied areas of Biotechnology

We are thankful to our below Honourable guests and Keynote Speakers for their generous support and suggestions.

Manfred T Reetz Philipps-University, Germany

W Tim Miller - Echelon-Frontier Scientific Inc, USA

Wilfried Schwab - Technische Universitt Mnchen, Germany

Aline Zimmer- Merck Millipore, Germany

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote-presentations:

Increasing the efficiency of directed evolution of enzymes: Manfred T Reetz, Philipps-University of Marburg, Germany

Trade secrets and laboratory security: Frontier Scientific Inc, USA

Aroma glucoside production: Wilfried Schwab, Technische Universitt Mnchen, Germany

Chemically modified cysteine in fed-batch processes and impact on CHO specific productivity: Aline Zimmer, Merck Millipore, USA

Synthetic mRNAs present a rapidly growing technology: Optimized tool for stem cell generation and for manipulating cellular phenotypes : Guido Krupp, Amptec GmbH, Germany

Novel synthetic anti-microbial defensins through confrontational selection and screening of yeast libraries: K Yankulov, University of Guelph, Canada

Long acting recombinant glycoprotein hormones: From bench to clinics, Fuad Fares, University of Haifa, Israel

Poster Session was judged by K Yankulov, University of Guelph, Canada

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Euro Biotechnology-2015. We are glad to inform that all accepted abstracts for the conference have been published in OMICS Group Journal of Biotechnology & Biomaterials as a special issue.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance. With the unique feedback from the conference, OMICS Group would like to announce the commencement of the 11th Euro Biotechnology Congress" to be held during November 07-09, 2016 at Alicante, Spain

Let us meet Again @ Euro Biotechnology-2016

Biotechnology-2014

OMICS Group Conferencessuccessfully hosted its premier5thWorld Congress on Biotechnologyduring June25-27, 2014 Valencia Conference centre, Valencia Spain

This World congress was accomplished by the support of European Biotechnology Thematic Network Association (EBTNA), Valencia Bioregion (BIOVAL), Federation of Spanish Biotechnologist (FEBiotec) and Societ Italo-Latinoamericana di Etnomedicina (SILAE). Biotechnology-2014 marked with the attendance of Editorial Board Members of supported OMICS Group Journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference fruitful and productive.

This5thWorld Congress on Biotechnologywas based on the theme the theme Biotechnology: Meeting the Needs of a Changing World which has covered the below scientific sessions:

The conference was greeted by the welcome message ofProf. Cheorl-Ho KimSung Kyun Kwan University, Korea and moderated byProf. Martin J. DSouza, Mercer University, USA. The support was extended by the below honourable guest Em. Prof.Marc Van Montagu, (World Food Laureate 2013) University of Gent, Belgium, Prof.Roberto Gaxiola, Arizona State University, USA, Prof.Ara Kanekanian, Cardiff Metropolitan University, UK, Prof.Manuel P. Alonso,University of Valencia, Spain, Prof.Cheorl-H. Kim,Sung Kyun Kwan University,Dr. Srinubabu Gedela, OMICS Group Inc, USA and below keynote lectures:

OMICS GroupInternational acknowledge the support of below Chairs and Co-chairs foe whom we were able to run smoothly the scientific sessions includes: Alain Goossens, Ghent University, Belgium, Oscar Vicente, IBMCP, Polytechnic University of Valencia, Spain, Ara Kanekanian, Cardiff Metropolitan University, UK, Ana M. Hortigela, Instituto de Medicina Genmica, Spain, Cheorl-H Kim, Sung Kyun Kwan University, Korea, Martin J. DSouza, Mercer University, USA, Marina V. Frontasyeva, Joint Institute for Nuclear Research, Russian Federation, Zlatka Alexieva, Bulgarian Academy of Sciences, Bulgaria, Salvador Ventura, Universitat Autnoma de Barcelona, Spain, Giuseppe Manco, Institute of Protein Biochemistry, National Research Council (CNR), Italy, Aihua Liu, Qingdao Institute of Bioenergy & Bioprocess, CAS, China, Amparo Pascual-Ahuir Giner, Universidad Politecnica de Valencia, Spain.

Visit link:
Euro Biotechnology Congress

Posted in Biotechnology | Comments Off on Euro Biotechnology Congress

Orthopedic Stem Cell Treatments – Orthopedics – Stem Cell …

Posted: September 15, 2016 at 9:43 am

Orthopedic injuries and degenerative joint diseases are some of the most common conditions which cause discomfort and disability. Arthritis ,and the trauma which leads to loss of cartilage and injured tendons and ligaments from sports is common among athletes.

There are many procedures which have been tried with various success rates, ranging from micro fracture to stimulate cartilage growth and Platelet Rich Plasma Injections to strengthen ligaments and tendons. Our study of the use of SVF which contains the stem cells is underway for many of these conditions.

The use of stem cell therapy in Orthopedics is one of the most studied use world wide. Here at the Hawaii Stem Cell Treatment Center we use the stem cell broth of Stromal Vascular Fraction (SVF) and deploy that to the area of concern. This may be the knees , elbows, shoulders, hands, hips or spine.

The deployment is carried out in our center which maintains the highest standards of sterility by using our networks patented closed system of deployment. There is minimal manipulation during the harvesting and processing of the SVF which comes from your own fat. For certain areas such as the hip or spine we may make use of imaging to assure exact placement of the SVF.

Additionally we use other specialist such as invasive radiologist and orthopedic specialist in many cases to carry out this deployment. Our network uses the same orthopedic protocols and maintains an extensive shared data base in which your data will be entered if accepted in these research protocols.

Read more here:
Orthopedic Stem Cell Treatments - Orthopedics - Stem Cell ...

Posted in Hawaii Stem Cells | Comments Off on Orthopedic Stem Cell Treatments – Orthopedics – Stem Cell …

Stem Cells | Topics | Christianity Today

Posted: September 13, 2016 at 11:46 pm

(UPDATED) ALS raises $100 million in 30 days; pro-life groups worry about embryonic research.

Morgan Lee / August 29, 2014

Biotech advances could make destroying human embryos for research a relic of the past.

Bob Smietana / November 22, 2013

Human cells have been resistant to cloninguntil now.

Christine A. Scheller / May 15, 2013

The new executive director at the Center for Bioethics and Human Dignity discusses recent bioethical debates.

Interview by Alicia Cohn / July 23, 2009

Access to federal money may be mixed blessing for embryonic research.

Sarah Pulliam / April 23, 2009

Why scientific breakthroughs make the destruction of human embryos obsolete.

Rep. Mike Pence / March 23, 2009

When science is made 'apolitical' and 'unencumbered by religion,' it's usually to hyper-politicize and hyper-sacralize it.

Mollie Ziegler Hemingway / March 23, 2009

Where the parties stand on abortion, faith-based programs, religious liberty, and other issues.

August 27, 2008

All three candidates have voted to fund embryonic stem-cell research.

Sarah Eekhoff Zylstra / April 9, 2008

Advances in stem-cell technology cheer and alarm ethics watchers.

Sarah Eekhoff Zylstra / November 16, 2007

Plus: Surgeon general nominee's Methodist work under fire, Time interviews Rowan Williams, church building conflicts, and other stories from online sources around the world.

Compiled by Ted Olsen / June 8, 2007

Why we struggle to gain our moral footing in bioethics.

A Christianity Today Editorial / March 1, 2007

Research advance could shift stem-cell debate.

Sarah Pulliam / February 12, 2007

Fear of mortality lies at the root of our bioethics confusion.

A Christianity Today Editorial / January 2, 2007

It's hard to see the humanity of tiny embryos if we live by blind faith.

Stan Guthrie / November 9, 2006

Embryonic stem cells factor in the race for Henry Hyde's U.S. House seat.

Collin Hansen / November 2, 2006

A new statement from Evangelicals and Catholics Together encourages discourse on the most divisive of issues.

David Neff / October 10, 2006

Plus: Prolifers rally and ... burn the Qur'an?! On having Ralph Reed to kick around, banning baths, and a bunch of links to a bunch of other stories.

Compiled by CT staff / July 21, 2006

Plus: The latest from the Korean cloning scandal.

Nigel M. de S. Cameron / April 27, 2006

The "anti-Genesis" of those who play God, and why the biotech business needs to take ethics seriously.

Nigel M. de S. Cameron / April 19, 2006

Tomorrow's "godlike massively intelligent machines." Plus: Our nanotech future and some good news on stem cells that really work.

Nigel M. de S. Cameron / April 12, 2006

Plus: Good news from Europe on stem-cell funding.

Nigel M. de S. Cameron / April 5, 2006

Plus: The latest on the biopolicy agenda and some outrageous lies on stem cells.

Nigel M. de S. Cameron / March 30, 2006

The U.K. and disaffected American researchers lash out at U.S. cloning laws.

Nigel M. de S. Cameron / March 17, 2006

How to sell unethical science.

Nigel M. de S. Cameron / March 2, 2006

The latest sad story from the Korean soap operaand a lack of Talent in Missouri.

Nigel M. de S. Cameron / February 17, 2006

President Bush sets out a vital agenda for ethics.

Nigel M. de S. Cameron / February 2, 2006

From the frying pan into the fire.

Nigel M. de S. Cameron / January 20, 2006

C. S. Lewis was way ahead of the curve.

by Nigel M. de S. Cameron / November 30, 2005

And they may end up in a laboratory near you.

by Nigel M. de S. Cameron / November 2, 2005

What Americans really think about science: astonishing new polling data.

by Nigel M. de S. Cameron / October 26, 2005

The Majority Leader's contradictions mirror the opinions of the public at large.

by Nigel M. de S. Cameron / October 11, 2005

Remember Prop. 71? Stem-cell research supporters hope voters don't remember the promises they made.

by Nigel M. de S. Cameron / October 5, 2005

The little-known story of the stem cells that actually work.

David A. Prentice / September 30, 2005

What does it mean when even embryonic stem-cell researchers have some qualms about their work?

by Christine A. Scheller / September 29, 2005

Pro-lifers face a scientific and public relations juggernaut.

by Stan Guthrie with Agnieszka Tennant, Sheryl Henderson Blunt in Washington, and Rob James in the United Kingdom / September 28, 2005

The man who led the President's Council on Bioethics brought protests from the industry and directed groundbreaking studies.

by Nigel M. de S. Cameron / September 21, 2005

The Washington Post muddles a major breakthrough in adult stem-cell research, while the U.K. marches blindly on.

by Nigel M. de S. Cameron / August 29, 2005

Introducing our new life ethics weblog.

by Nigel M. de S. Cameron / August 10, 2005

Killing human embryos for research is not pro-life.

by Stan Guthrie / August 2, 2005

Read this article:
Stem Cells | Topics | Christianity Today

Posted in Missouri Stem Cells | Comments Off on Stem Cells | Topics | Christianity Today

Stem Cell Treatments | Stem Cell Therapy Colorado

Posted: September 13, 2016 at 11:43 pm

Stem cell treatments for musculoskeletal conditions such as arthritis, tendonitis, cartilage and ligament injury are on the cutting edge of medicine and are now a reality. The latest treatments use a patients own blood, fat or bone marrow, therefore the ethical concerns over fetal involvement have been eliminated.

Stem cells still have the capability of turning into multiple cell lines such as cartilage, tendon, skin, muscle, bone and more. All of the stem cell therapies provided at Colorado Clinic either contain stem cells directly, or call in the bodys own stem cells for regeneration and repair of the damaged tissue.

Currently, there are four common stem cell and regenerative treatments available at Colorado Clinic to assist with ligament injury, tendonitis, tendinosis, joint and spinal arthritis treatment or cartilage injury. This may include an achilles tendon problem, rotator cuff, facet arthritis, tennis elbow or typical wear and tear degenerative arthritis of the hip, knee, wrist, shoulder, ankle etc.

For more information on each of the various stem cell injection treatment options offered at Colorado Clinic, simply click on any of the following:

Colorado Clinic focuses on outpatient treatment with stem cell injections for soft tissue injuries and joint or spinal arthritis.

Request Appointment for Stem Cell Injection Treatments that are often partially covered by insurance!

See more here:
Stem Cell Treatments | Stem Cell Therapy Colorado

Posted in Colorado Stem Cells | Comments Off on Stem Cell Treatments | Stem Cell Therapy Colorado

Stem Cell Treatment – Anchorage Alaska Spine & Pain Clinic

Posted: September 12, 2016 at 3:43 am

What is Stem Cell Therapy?

Stem Cell Therapy utilizes the patients own stem cells to replace dying cells and regenerate damaged tissue to eliminate pain. These cells are obtained from the patients own bone marrow or fat tissues through a sterile closed surgical process. The cells are isolated in a centrifuge and injected into the pain site to begin healing. The cells are collected and injected on the same day using specialized imaging technology to ensure the most effective treatment.

Stem Cell Therapy accelerates the bodys own natural healing processes and is effective for treating pain. When the body is injured, adult stem cells are dispatched to the area of the injury to regenerate healthy cells, but this isnt always enough. Stem Cell Therapy collects concentrated amounts of stem cells from healthy areas of the body, and injects the cells directly into the area of injury. Stem Cell Therapy is effective for many types of tissue including cartilage, tendons, ligaments, bone, and fibrous connective tissue. Stem Cell Therapy reduces pain and promotes healing without the need for pain medications or steroid injections.

Dr. Johnson and his compassionate staff at AA Spine & Pain Clinic believe that no one should have to live in pain. We will take the time to educate our patients about their conditions and their available treatment options so they can make the best decisions about their care. Each patient will receive individualized treatment based on their specific needs to ensure the best possible outcome.

You may be considering stem cell therapy if you suffer from ongoing pain from an injury or if you are currently managing pain through medication or injection therapy. Stem Cell Therapy is a relatively new procedure and is not yet covered by most insurances. We want to provide the best treatment options for your pain, and will review your specific situation and treatment options with you.

Each Stem Cell Therapy procedure is performed in our medical office and usually takes less than an hour to complete. It does not require surgery, general anesthesia, or hospital stays. Most people find they can return to work the day after receiving Stem Cell Therapy, but strenuous physical exercise should be avoided for several weeks afterwards to promote healing and to prevent injury.

See the rest here:
Stem Cell Treatment - Anchorage Alaska Spine & Pain Clinic

Posted in Alaska Stem Cells | Comments Off on Stem Cell Treatment – Anchorage Alaska Spine & Pain Clinic

Stem Cell Hair Growth Huntsville | Steve Latham Hair …

Posted: September 12, 2016 at 3:43 am

Stem Cell Hair Growth Home Stem Cell Hair Growth Hair Transplant Clinic Huntsville, Alabama Give us a call today at (256) 382-2000!

Stem cells are special cells that have the remarkable capacity to morph into all of the 220 types of cells that a human being is composed of. Specifically, stem cells can regenerate themselves without losing their ability to morph into any other cell type. As the cells in our bodies that make our organs must always be renewed, and the failure to do so successfully is essentially the root cause of aging and disease, the application of stem cells in rejuvenating human cells to treat a variety of aging symptoms is quite promising.

Of course, balding is no exception, and it appears that moving forward stem cell hair growth will be the preferred hair loss treatment. No matter what the cause of balding is, what happens when we lose our hair is that our hair follicles -the small glands from which hair grows out of- shrink to a point where hair can no longer grow out of them. Stem cell hair growth is genetic regeneration of hair follicles. This is why at Steve Latham Hair Transplant Clinic we provide the stem cell hair growth Huntsville, AL residents can be assured is effective.

Without getting too far into the specifics of the complicated biological processes, there are two main ways stem cells can be used to regenerate stem cell hair growth. Both of these are covered by our procedures at Steve Latham Hair Transplant Clinic. Our stem cell hair growth Huntsville, AL hair loss sufferers have used for years is proven to tackle both major aspects.

The first way involves using human stem cells that are harvested from the fatty material (adipose is the technical term) around the belly button. Products and treatments containing these adipose stem cells have proven existingto be very successful in hair follicle repair and subsequent hair growth.The other way involves stimulating the stem cell material that is still present in your hair follicles.

Whether its through the application of new stem cells, or activation of your already existing stem cells in your scalp, at Steve Latham Hair Transplant Clinic in Huntsville, AL, we can find the stem cell hair treatment that is right for you through careful diagnosis and consultation. We perform the stem cell hair growth Huntsville, AL residents can always trust to be effective.

See the original post here:
Stem Cell Hair Growth Huntsville | Steve Latham Hair ...

Posted in Alabama Stem Cells | Comments Off on Stem Cell Hair Growth Huntsville | Steve Latham Hair …

Biotechnology , Undergraduate Programs, SUNY-ESF

Posted: September 9, 2016 at 7:45 pm

Biotechnology is the application of biological organisms, cells, or molecules to create products or services for the betterment of humans.

The bachelor of science degree in biotechnology prepares students to tackle environmental, natural resource, agricultural and medical problems through training in molecular biology, cell biology, biochemistry, genetic engineering and related biological disciplines. As biotechnology is increasingly used to address such issues, it offers diverse career opportunities. The curriculum emphasizes the basic sciences with a strong foundation in biology, chemistry, calculus, and physics that prepares students for upper-level biology and chemistry courses, but encourages elective breadth in the social sciences, humanities, and environmental studies. The degree program provides sufficient breadth for a student to enter a clinical medical career, or other health profession. Students who complete this major will be qualified to enter the growing biotechnology-related job market or continue their studies in graduate or professional school.

The biotechnology major features a strong practical experience component. Each student is required to fulfill an internship, which could be in a local, national, or international company, medical unit, or government research laboratory. The objective of this internship is to give students experience working outside a purely academic setting. In addition, each student is required to perform one independent research project in a local, national, or international academic laboratory. The objective of the research requirement is to teach the student to develop and meet a research goal using the scientific method. During the senior year, each student is required to complete a senior project synthesis in which the results from either the internship or independent researchor bothwill be organized and presented as a seminar or poster.

See original here:
Biotechnology , Undergraduate Programs, SUNY-ESF

Posted in Biotechnology | Comments Off on Biotechnology , Undergraduate Programs, SUNY-ESF

Palm Beach State – Biotechnology

Posted: September 9, 2016 at 7:45 pm

Sign Up today for our next free INFO SESSION!

Palm Beach State College offers two degree programs in biotechnology. Students may choose to enroll inthe Associate in Science (AS) degree, which prepares students for entry into the biotechnology workforce, academic research, and related industries; or a dual Associate in Arts (AA)/(AS) degree option, designed for pre-med and other students planning to transfer to a four-year university. Both the AS and dual AA/AS programs require students to complete a 4-month Biotech internship outside of the College that provides training in real-world academic or industry research.

Our award winning program is taught byPhD level scientific faculty and researchers committed to providing challenging courses to meet the needs of the growing biotech industry.

We also offera 19-credit Biotechnology College Credit Certificate (CCC) for studentswho already have a bachelor's degree and want to gain the in-demand skills employers require and the internship needed to get a high-tech job orto strengthen anapplication to graduate or medical school.

Palm Beach State's biotech business partnership, consisting of over 25 different biotech firms, allows our students unique internship opportunities which develop the skills and experience required for a successful career in the biotechnology field.

Information for Advisors and Prospective Students

To get started in our Biotechnology program or foradditional information pleasecontact:

Read the rest here:
Palm Beach State - Biotechnology

Posted in Biotechnology | Comments Off on Palm Beach State – Biotechnology

Biotechnology | Columbia University | Graduate School of Arts …

Posted: September 9, 2016 at 7:45 pm

Degree Programs: Full-Time/Part-Time: Free-Standing M.A.

Columbia Universitys Master of Arts in Biotechnology trains students in modern aspects of molecular biology with a particular emphasis on approaches used in the biotechnology and pharmaceutical industries. The curriculum focuses on the basic principles of biotechnology and specific applications in various fields. The use of biotechnology to fight disease is emphasized.

Thirty (30) points of course work plus a masters thesis are required for the M.A. in Biotechnology. The coursework includes three core courses, intensive laboratory experience and elective courses selected from the Department of Biological Sciences and a variety of other departments according to the students specific interests. The thesis includes a review of a topic in biotechnology. The program can be completed by full-time students in one year including the summer term or at a reduced pace by part-time students.

Research career in biotechnology:Anyone interested in becoming a research scientist in biotechnology will benefit from this program. The program covers basic and advanced aspects of biotechnology and allows students to start careers in research and development in the pharmaceutical and biotechnology industries.

Moderate biology background: Students with a moderate biology background have the opportunity to extend their course work in biotechnology and biological sciences and continue in these fields.

Regulatory affairs: Those interested in regulatory affairs and management in the biotechnology industry are able to enhance their previous or future training in these fields with a firm scientific background.

Management, investment, and patent law: Professionals in management, investment and patent law in the biotechnology industry are able to extend their knowledge of the science behind this industry, enabling them to make better decisions regarding this rapidly developing field.

Students wishing to apply for an M.D. or Ph.D.: Students interested in M.D. or Ph.D. programs are able to explore the field of biotechnology with a relatively short time commitment and increase their prospects for admission to top programs.

Read the original here:
Biotechnology | Columbia University | Graduate School of Arts ...

Posted in Biotechnology | Comments Off on Biotechnology | Columbia University | Graduate School of Arts …

FBIOX – Fidelity Select Biotechnology Portfolio | Fidelity …

Posted: September 9, 2016 at 7:45 pm

Objective

Seeks capital appreciation.

Investing primarily in companies engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. Normally investing at least 80% of assets in securities of companies principally engaged in these activities. Normally investing primarily in common stocks.

Stock markets, especially foreign markets, are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Foreign securities are subject to interest rate, currency exchange rate, economic, and political risks. Focus funds can be more volatile because of their narrow concentration in a specific industry. The biotechnology industry can be significantly affected by patent considerations, intense competition, rapid technological change and obsolescence, and government regulation. The fund may have additional volatility because it can invest a significant portion of assets in securities of a small number of individual issuers.

This description is only intended to provide a brief overview of the mutual fund. Read the fund's prospectus for more detailed information about the fund.

Excerpt from:
FBIOX - Fidelity Select Biotechnology Portfolio | Fidelity ...

Posted in Biotechnology | Comments Off on FBIOX – Fidelity Select Biotechnology Portfolio | Fidelity …

Page 1,709«..1020..1,7081,7091,7101,711..1,7201,730..»